Loading...
Outset Medical, Inc.
OM•NASDAQ
Healthcare
Medical - Devices
$18.53
$0.92(5.22%)
Outset Medical, Inc. (OM) Financial Performance & Income Statement Overview
Review Outset Medical, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
-12.80%
↓ 12.80%
Operating Income Growth
33.22%
↑ 33.22%
Net Income Growth
25.94%
↑ 25.94%
Operating Cash Flow Growth
11.47%
↑ 11.47%
Operating Margin
-80.56%
↓ 80.56%
Gross Margin
35.93%
↑ 35.93%
Net Profit Margin
-98.74%
↓ 98.74%
ROE
-145.40%
↓ 145.40%
ROIC
-34.78%
↓ 34.78%
Outset Medical, Inc. (OM) Income Statement & Financial Overview
Review Outset Medical, Inc.'s (OM) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $29.47M | $28.67M | $27.39M | $28.17M |
| Cost of Revenue | $18.72M | $18.85M | $17.61M | $19.95M |
| Gross Profit | $10.75M | $9.82M | $9.78M | $8.21M |
| Gross Profit Ratio | $0.36 | $0.34 | $0.36 | $0.29 |
| R&D Expenses | $7.89M | $8.14M | $9.73M | $12.63M |
| SG&A Expenses | $24.72M | $25.52M | $30.81M | $32.49M |
| Operating Expenses | $32.61M | $33.66M | $40.55M | $45.13M |
| Total Costs & Expenses | $51.33M | $52.51M | $58.15M | $65.08M |
| Interest Income | $2.04M | $2.15M | $2.47M | $3.10M |
| Interest Expense | $5.83M | $6.07M | $6.01M | $5.97M |
| Depreciation & Amortization | $1.41M | $2.15M | $1.47M | $1.46M |
| EBITDA | -$18.41M | -$21.69M | -$26.82M | -$32.35M |
| EBITDA Ratio | -$0.62 | -$0.76 | -$0.98 | -$1.15 |
| Operating Income | -$21.86M | -$23.84M | -$30.76M | -$36.91M |
| Operating Income Ratio | -$0.74 | -$0.83 | -$1.12 | -$1.31 |
| Other Income/Expenses (Net) | -$3.78M | -$3.92M | -$3.54M | -$2.87M |
| Income Before Tax | -$25.64M | -$27.76M | -$34.30M | -$39.78M |
| Income Before Tax Ratio | -$0.87 | -$0.97 | -$1.25 | -$1.41 |
| Income Tax Expense | -$4000.00 | $182000.00 | $151000.00 | $162000.00 |
| Net Income | -$25.64M | -$27.94M | -$34.45M | -$39.94M |
| Net Income Ratio | -$0.87 | -$0.97 | -$1.26 | -$1.42 |
| EPS | -$0.49 | -$0.55 | -$0.66 | -$0.78 |
| Diluted EPS | -$0.49 | -$0.55 | -$0.66 | -$0.78 |
| Weighted Avg Shares Outstanding | $3.52M | $50.50M | $51.88M | $50.90M |
| Weighted Avg Shares Outstanding (Diluted) | $3.52M | $50.50M | $51.88M | $50.90M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan